Purchases and Sales Made in Q3 2022 in Atea Pharmaceuticals, Inc. (AVIR)
This table provides information about the institutional ownership of Atea Pharmaceuticals, Inc. (AVIR) during Q3 2022. The information is specifically focused on institutions that hold shares of Atea Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2022
Q3 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-51.9K- 12.01% |
$285K - $456K
|
381K
$1.23M
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-65.6K- 9.89% |
$360K - $577K
|
597K
$1.94M
|
|
Nov 14, 2022
Q3 2022
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-77.8K- 71.83% |
$427K - $684K
|
30.5K
$98.9K
|
|
Nov 04, 2022
Q3 2022
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-84.7K- 22.33% |
$465K - $745K
|
295K
$955K
|
|
Nov 14, 2022
Q3 2022
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-156K- 2.46% |
$855K - $1.37M
|
6.18M
$20M
|
|
Nov 14, 2022
Q3 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-236K- 88.38% |
$1.29M - $2.07M
|
31K
$100K
|
|
Nov 14, 2022
Q3 2022
|
K2 Principal Fund, L.P.
Toronto, A6 |
SELL
|
- |
-1M- 62.3% |
$5.49M - $8.8M
|
605K
$1.96M
|
|
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-1.05M- 58.26% |
$5.76M - $9.22M
|
751K
$2.43M
|